3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
3
Unknown
2
Recruiting
2
Withdrawn
1
Not yet recruiting
1
Enrolling by invitation
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
2
Myeloid
2
Conditions
Neoplasms
38
Breast Neoplasms
31
Lung Neoplasms
25
Colorectal Neoplasms
15
Prostatic Neoplasms
13
Pancreatic Neoplasms
11
Ovarian Neoplasms
11
Head and Neck Neoplasms
10
Carcinoma, Non-Small-Cell Lung
10
Sarcoma
8
Colonic Neoplasms
8
Uterine Cervical Neoplasms
7
Melanoma
7
Glioma
7
Esophageal Neoplasms
7
Carcinoma, Hepatocellular
7
Lymphoma
6
Stomach Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
5
Neoplastic Cells, Circulating
5
Multiple Myeloma
5
Endometrial Neoplasms
5
Brain Neoplasms
5
Neoplasm, Residual
4
Gastrointestinal Neoplasms
4
Carcinoma, Squamous Cell
4
Carcinoma, Renal Cell
4
Adenocarcinoma
4
Thrombosis
3
Skin Neoplasms
3
Interventions
venetoclax
27
fludarabine
26
Cyclophosphamide
25
Specimen Handling
20
Azacitidine
20
Biopsy
15
Whole-Body Irradiation
14
Cytarabine
14
Stem Cell Transplantation
13
Decitabine
13
Tacrolimus
12
Melphalan
12
fludarabine phosphate
11
Mycophenolic Acid
11
Busulfan
11
Injections
9
X-Rays
7
Thiotepa
7
Hematopoietic Stem Cell Transplantation
7
Granulocyte Colony-Stimulating Factor
7
decitabine and cedazuridine drug combination
6
Cyclosporine
6
ruxolitinib
5
Magnetic Resonance Spectroscopy
5
Idarubicin
5
Filgrastim
5
gilteritinib
4
Sirolimus
4
Peripheral Blood Stem Cell Transplantation
4
Cyclosporins
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Myelodysplastic Syndromes
×
Blood Specimen Collection
×
Clear all
NCT06510868
2026-03-05
MDS & PRRT
University Health Network, Toronto
Recruiting
45 enrolled
NCT05983991
2025-12-26
GATA-2
Institut Claudius Regaud
Phase NA
Recruiting
150 enrolled